Kraig Biocraft Laboratories Completes Phase One of its Spider Silk Production Facility Expansion
15 juil. 2024 07h05 HE
|
Kraig Biocraft Laboratories
Kraig Labs (OTCQB: KBLB) completed the first phase of construction for its production facility expansion to support the Company's third production wave
Kraig Biocraft Laboratories Announces New Spider Silk Production Contract
08 juil. 2024 07h05 HE
|
Kraig Biocraft Laboratories
Kraig Labs (OTCQB:KBLB) signs production agreement for its recombinant spider silk technology, building on its new spider silk production hybrids success
Kraig Biocraft Laboratories Expands Facilities to Support Spider Silk Production Growth
01 juil. 2024 08h05 HE
|
Kraig Biocraft Laboratories
Kraig Labs (OTCQB: KBLB) achieved full capacity at its current production location and will open additional production facilities
Kraig Biocraft Laboratories Increases Spider Silk Production with Next Generation of Hybrid Eggs Completed
25 juin 2024 07h05 HE
|
Kraig Biocraft Laboratories
Kraig Labs (OTCQB: KBLB) expanded its production of spider silk with the creation of the next generation of BAM-1 hybrid
Kraig Biocraft Laboratories Successfully Completes Cocooning in First Commercial Production Run of BAM-1 Spider Silk Hybrids
17 juin 2024 07h05 HE
|
Kraig Biocraft Laboratories
Kraig Labs (OTCQB: KBLB) successfully completed cocoon production for the first commercial production run of its BAM-1 hybrids
Kraig Biocraft Laboratories Announces Production Update for BAM-1 Spider Silk Hybrids
11 juin 2024 07h05 HE
|
Kraig Biocraft Laboratories
Kraig Labs’ (OTCQB: KBLB) BAM-1 spider silk hybrid strain continues to set records for silkworm size, growth, and robustness.
Kraig Biocraft Laboratories Announces BAM-1 Spider Silk Hybrids are in Production
03 juin 2024 07h05 HE
|
Kraig Biocraft Laboratories
Kraig Labs (OTCQB: KBLB) is now in production with its BAM-1 spider silk hybrids, following the resounding successes of its spring production trials
Kraig Biocraft Laboratories Spring Spider Silk Production Trials Exceed Expectations
09 mai 2024 08h05 HE
|
Kraig Biocraft Laboratories
Kraig Labs (OTCQB:KBLB) BAM-1 spider silk spring production trials exceed expectations and Implementing Next Phase of Its Recombinant Spider Silk Plan
Kraig Biocraft Laboratories Reports Signing Landmark Agreements in South East Asia
29 avr. 2024 07h05 HE
|
Kraig Biocraft Laboratories
Kraig Labs (OTCQB: KBLB) signs key agreements with Lam Dong Agro-Forestry Research Experiment Center for spider silkworm rearing and breeding
Kraig Biocraft Laboratories Successfully Completes Recombinant Cocoon Production From Spring Trials
22 avr. 2024 07h05 HE
|
Kraig Biocraft Laboratories
Kraig Labs (OTCQB: KBLB) achieves major milestone; completes new BAM-1 1st gen parental strain rearing and cocoons at rates that exceeded expectations